The sources said that the challenges in uniform implementation and enforcement, interchangeable usage of the same nutrient/ingredient at different doses for pharma and nutraceutical use and overlap in phylactic and therapeutic usage along with disease risk reduction claims were discussed with the Central Drugs Standard Control Organisation (CDSCO) officials in a recent meeting.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/bOqQgu1
0 Comments